News

In addition, the committee also favoured the risk-benefit profile of raxibacumab. The raxibacumab anti-toxin development programme has been designed to get approval under the regulatory pathway using animal

Developed at pharma grade Wadenswil, Switzerland facility, the EFLA HyperPure technology, which the company claims to be safe and effective, utilizes cross flow membrane microfiltration process to separate

Sevuparin is an adjunctive therapy to anti-parasite medicines to prevent the infected red blood cells from obstructing blood vessels to reduce mortality. The grant from Vinnova will be

FLD causes lipid deposition in eyes, red blood cells and kidneys which can lead to corneal opacity, hemolytic anemia and kidney failure respectively. ACP-501, being developed to treat

Total revenues for third quarter of 2012 were $884.14m compared to $600.58m for the third quarter of 2011. The company reported a net loss of $26.88m, or $0.09

The open-label study of 198 patients, who have developed the syndrome during an outbreak in Germany, demonstrated significant and persistent progression in thrombotic microangiopathy (TMA) and setback of

The OncoGenomics Explorer solution will provide Bayer with a centralized access to unified global genomics data for utilization across the entire research organization from target discovery to drug

The new Sorvall LYNX centrifuge runs with 100,000 x g top speed and supports high-throughput sample processing from 50 mL conical tubes and microplates to 1 L bottles,

Health Canada asked Novartis to suspend distribution of Agriflu and Fluad on 26 October 2012 as precautionary measure. The Public Health Agency of Canada, which monitors vaccination-related adverse